Allergan plc (NYSE:AGN)

155.95
Delayed Data
As of May 23
 +0.97 / +0.63%
Today’s Change
142.81
Today|||52-Week Range
256.80
-4.66%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2014

2015

2016

2017
Revenue and IncomeNet Revenues13.1B15.1B14.6B15.9B
 
 
 
 
 
Cost of Goods Sold6.1B4.6B1.7B2.1B
 
 
 
 
 
Depreciation And Amortization2.8B5.6B6.6B7.4B
 
 
 
 
 
 
Operating ExpensesGross Income4.2B4.9B6.3B6.4B
 
 
 
 
 
General Expenses4.2B5.7B6.9B6.7B
 
 
 
 
 
Research And Development1.1B2.1B2.6B2.0B
 
 
 
 
 
Total Operating Expenses13.1B15.9B15.2B16.2B
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-26.7M-834.3M-664.3M-285.0M
 
 
 
 
 
Extraordinary Credit102.1M31.0M238.5M183.2M
 
 
 
 
 
Extraordinary Charge-1.1B-2.2B-1.2B-5.4B
 
 
 
 
 
Interest Expense On Debt485.4M1.5B1.3B1.1B
 
 
 
 
 
Other Expenses-188.6M-10.1M64.2M-3.9B
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-1.7B-4.4B-2.8B-10.4B
 
 
 
 
 
Income Taxes-81.9M-1.6B-1.9B-6.7B
 
 
 
 
 
Minority Interest-300.0K-4.2M-6.1M-6.6M
 
 
 
 
 
Preferred Dividend0.00-232.0M-278.4M-278.4M
 
 
 
 
Discontinued Operations0.006.8B15.9B-402.9M
 
 
 
 
Net Income-1.6B3.9B15.0B-4.1B
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS219.7M367.8M384.9M333.8M
 
 
 
 
 
Shares To Calculate EPS Diluted219.7M367.8M384.9M333.8M
 
 
 
 
 
 
Earnings Per ShareEPS-$7.42$10.01$38.18-$13.19
 
 
 
 
 
EPS Diluted-$7.42$10.01$38.18-$13.19